

Senate
File
362
-
Introduced


SENATE
FILE
362


BY
BEALL
,
KIBBIE
,
DANIELSON
,


BEHN
,
FEENSTRA
,
DIX
,
SMITH
,


and
SORENSON


A
BILL
FOR


An
Act
relating
to
the
use
of
adult
stem
cells
in
this
state,
1


including
uses
relating
to
the
practice
of
medicine,
the
2


practice
of
pharmacy,
and
clinical
research.
3


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4


TLSB
2604XS
(6)
84


pf/nh



S.F.
362


Section
1.
NEW
SECTION
.
136E.1
Definitions.
1


As
used
in
this
chapter
unless
the
context
otherwise
2


requires:
3


1.
“Adult
stem
cells”
means
autologous
or
allogeneic
4


cellular
material
including
but
not
limited
to
stem
cells,
5


immune
cells,
and
other
types
of
mature
cells
that
may
have
6


been
or
may
be
combined
with
naturally
occurring
biomaterials
7


or
materials
approved
or
cleared
for
any
purpose
by
the
United
8


States
food
and
drug
administration
or
other
applicable
agency
9


or
authority.
10


2.
“Allogeneic”
means
originating
from
the
body
of
another
11


person.
12


3.
“Autologous”
means
originating
from
a
person’s
own
body.
13


4.
“Cell
or
tissue
bank”
means
a
facility
that
stores
adult
14


stem
cells
or
tissue.
15


Sec.
2.
NEW
SECTION


.
136E.2
Practices
relating
to
adult
16


stem
cells.
17


1.
Notwithstanding
any
law
to
the
contrary:
18


a.
A
person
licensed
to
practice
medicine
pursuant
to
19


chapter
148
in
this
state
may
extract,
process,
or
administer
20


autologous
adult
stem
cells.
21


b.
A
person
licensed
or
authorized
to
administer
or
assist
22


in
the
administration
of
medicine
or
health
care
in
this
state
23


may
extract,
process,
or
administer
autologous
adult
stem
24


cells
to
the
extent
permitted
under
the
person’s
license
or
25


authorization.
26


c.
A
person
may
operate
a
cell
or
tissue
bank
in
this
state.
27


d.
A
pharmacy
owned
or
operated
in
this
state,
or
a
28


pharmacist
licensed
pursuant
to
chapter
155A,
may
compound
a
29


drug,
medicine,
or
health
product
using
adult
stem
cells
as
an
30


ingredient.
31


e.
A
person
licensed
to
practice
medicine
in
this
state
may
32


conduct
adult
stem
cell
clinical
research
for
development
of
33


therapies
and
cures
consistent
with
chapter
707C.
This
chapter
34


shall
not
be
interpreted
to
limit
or
prohibit
any
activity
35


-1-


LSB
2604XS
(6)
84


pf/nh


1/
4





S.F.
362


otherwise
authorized
pursuant
to
chapter
707C.
1


f.
A
person
authorized
to
conduct
adult
stem
cell
clinical
2


research
in
the
state
may
import
into
this
state
any
compound
3


or
drug
containing
adult
stem
cells
if
the
compound
or
drug
is
4


obtained
in
accordance
with
the
laws
of
the
jurisdiction
from
5


which
the
compound
or
drug
is
obtained
and
the
compound
or
drug
6


is
used
for
the
purposes
of
clinical
research.
7


g.
A
person
who
is
authorized
to
extract,
process,
or
8


administer
autologous
adult
stem
cells
under
this
section
9


may
import
into
this
state
compounds
and
drugs
used
in
the
10


administration
of
such
stem
cells
if
the
compound
or
drug
is
11


obtained
in
accordance
with
the
laws
of
the
jurisdiction
from
12


which
the
compound
or
drug
is
obtained
and
the
compound
or
drug
13


is
used
for
administration
of
autologous
adult
stem
cells
to
a
14


person
in
a
treatment
plan
by
a
person
licensed
or
authorized
15


to
extract,
process,
or
administer
autologous
adult
stem
cells.
16


2.
a.
The
board
of
medicine,
the
board
of
pharmacy,
and
17


other
appropriate
licensing
boards
established
pursuant
to
18


chapter
147
shall
adopt
rules
in
accordance
with
this
chapter.
19


The
rules
adopted
shall
not
prohibit
the
activities
authorized
20


in
this
chapter
and
shall
not
impose
disciplinary
action
or
21


civil
or
criminal
penalties
against
a
person
for
engaging
22


in
any
activity
authorized
by
this
chapter.
This
paragraph
23


shall
not
be
interpreted
to
authorize
the
adoption
of
rules
24


that
absolve
a
person
from
civil
or
criminal
liability
or
25


disciplinary
action
otherwise
applicable
if
the
person
engages
26


in
an
activity
authorized
under
this
chapter
but
fails
to
use
27


the
reasonable
care,
skill,
or
knowledge
ordinarily
used
in
28


rendering
medical
services
under
similar
circumstances.
29


b.
The
board
of
medicine,
the
board
of
pharmacy,
and
other
30


appropriate
licensing
boards
may
adopt
rules
to
regulate
the
31


procedures
used
to
administer
adult
stem
cells
in
this
state.
32


EXPLANATION
33


This
bill
relates
to
the
use
of
adult
stem
cells
in
the
34


state,
including
uses
relating
to
the
practice
of
medicine,
the
35


-2-


LSB
2604XS
(6)
84


pf/nh


2/
4



S.F.
362


practice
of
pharmacy,
and
clinical
research.
1


The
bill
defines
terms
used
in
the
bill
and
authorizes
2


certain
activities
relating
to
adult
stem
cells.
The
bill
3


authorizes
a
person
licensed
to
practice
medicine
in
the
state
4


to
extract,
process,
or
administer
autologous
adult
stem
cells.
5


“Autologous”
means
originating
from
the
person’s
own
body.
6


The
bill
also
provides
that
a
person
licensed
or
authorized
7


to
administer
or
assist
in
the
administration
of
medicine
or
8


health
care
in
this
state
may
extract,
process,
or
administer
9


autologous
adult
stem
cells
to
the
extent
permitted
under
the
10


person’s
license
or
authorization.
11


The
bill
authorizes
all
of
the
following:
the
operation
12


of
a
cell
or
tissue
bank
in
this
state;
a
pharmacy
owned
or
13


operated
in
the
state
or
a
licensed
pharmacist
to
compound
14


a
drug,
medicine,
or
health
product
using
adult
stem
cells
15


as
an
ingredient;
a
person
licensed
to
practice
medicine
to
16


conduct
adult
stem
cell
clinical
research
for
development
of
17


therapies
and
cures
consistent
with
Code
chapter
707C
(human
18


stem
cell
research
and
cloning)
while
clarifying
that
the
19


bill
is
not
to
be
interpreted
as
limiting
or
prohibiting
20


any
activity
authorized
under
chapter
707C;
a
person
who
is
21


authorized
to
conduct
adult
stem
cell
clinical
research
to
22


import
any
compound
or
drug
containing
adult
stem
cells
if
23


the
compound
or
drug
is
obtained
in
accordance
with
the
laws
24


of
the
originating
jurisdiction
and
is
used
for
clinical
25


research;
and
a
person
who
is
authorized
to
extract,
process,
26


or
administer
autologous
adult
stem
cells
to
import
compounds
27


and
drugs
used
in
the
administration
of
such
stem
cells
if
the
28


compound
or
drug
is
obtained
in
accordance
with
the
laws
of
the
29


originating
jurisdiction
and
the
compound
or
drug
is
used
for
30


administration
of
autologous
adult
stem
cells
to
a
person
in
a
31


treatment
plan
by
a
person
licensed
or
authorized
to
extract,
32


process,
or
administer
autologous
adult
stem
cells.
33


The
bill
directs
the
board
of
medicine,
the
board
of
34


pharmacy,
and
other
appropriate
licensing
boards
to
adopt
rules
35


-3-


LSB
2604XS
(6)
84


pf/nh


3/
4



S.F.
362


in
accordance
with
the
bill,
but
provides
that
the
rules
shall
1


not
prohibit
the
activities
authorized
in
the
bill
and
shall
2


not
impose
disciplinary
action
or
civil
or
criminal
penalties
3


against
a
person
for
engaging
in
any
activity
authorized
4


under
the
bill.
However,
the
bill
is
not
to
be
interpreted
5


to
authorize
the
adoption
of
rules
that
absolve
a
person
who
6


engages
in
an
activity
authorized
under
the
bill
from
civil
or
7


criminal
liability
or
disciplinary
action
otherwise
applicable
8


for
failure
to
use
the
reasonable
care,
skill,
or
knowledge
9


ordinarily
used
in
rendering
medical
services
under
similar
10


circumstances.
The
bill
does
authorize
the
board
of
medicine,
11


the
board
of
pharmacy
and
other
appropriate
licensing
boards
to
12


adopt
rules
to
regulate
the
procedures
used
to
administer
adult
13


stem
cells
in
this
state.


14


-4-


LSB
2604XS
(6)
84


pf/nh


4/
4

